Larvol Delta - Imara-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-IND-for-Tovinontrine-IMR687-for-Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF

tovinontrine (IMR-687) - Imara, Inc

https://www.globenewswire.com/news-release/2022/01/25/2372350/0/en/Imara-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-IND-for-Tovinontrine-IMR-687-for-Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF.html

Jan 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next